An early experience with the Senhance surgical robotic system in colorectal surgery: a single-institute study

Background We present our initial single-centre experience with Senhance surgical robot-assisted colorectal surgery and examine its safety and feasibility. Methods From June 2019 to December 2019, patients who underwent Senhance surgical robot-assisted colorectal surgery in our hospital were retrospectively analysed. We focused on the short-term outcomes. Results In total, 46 patients were enrolled in the study. Colorectal cancer was the most common indication for surgery (39 patients). The median total operation time was 283 min, and the median blood loss was 50 cc. Meanwhile, the median number of harvested lymph nodes was 20. Elderly age, advanced American Society of Anaesthesiologists stage, and right-sided colon surgery were associated with the occurrence of complications greater than grade III. Conclusion Our findings demonstrate the feasibility and safety of the Senhance surgical robotic system in colorectal surgery. Care should be taken regarding the indications and patient selection.

Automated summary

This study retrospectively analyzed 46 patients who underwent Senhance surgical robot-assisted colorectal surgery, demonstrating the feasibility and safety of the system in colorectal surgery, but caution should be exercised in the selection of indications and patients.